Program (Subject to Change)

  • 2019 CPhI China Panel Discussion: How can International and Domestic manufacturers collaborate to improve quality?
2019 CPhI China Panel Discussion: How can International and Domestic manufacturers collaborate to improve quality?
Download

Share:

Share the program with your friends

View in Mobile

Date:06月20日 11:00 - 06月20日 12:30

Language: Chinese-English

Location:Hall E1 M13 Meeting Room

Organizer:CCCMHPIE, Informa Markets

Introduction:Amidst a history of quality concerns and ongoing issues – in 2018 China received more warning letters issued to sites than any other country – the Chinese Pharma Market is undergoing a period of development as it further aligns itself with Western standards. Increased attention is now being paid to compliance with quality standards, as China upgrades its GMP requirements. This panel will address how both domestic and international manufacturers can work collaboratively to improve quality standards.

Description:

  • 11:00-12:30 Topics - What are the challenges facing Chinese manufacturers in the global market - The role of culture in the international landscape - International Harmonization and steps being taken to bring GMP in line with Global standards? - What are the risk-based approaches to manufacturing?

    Panel Member: Howard Sklamberg  Akin Gump  Partner

    Panel Member: Aurelio Arias  IQVIA  Senior Consultant

    Panel Member: Marieke van Dalen  Aspen Oss B.V  Global Regulatory Specialist

    Moderator: Frances Zipp  Lachmann Consultants  President & CEO; Vice Chair, International Board of Directors, ISPE

    Panel Member: Anil Kane  Patheon, part of Thermo Fischer Scientific  Executive Director, Global Head of Technical & Scientific Affairs

Sponsor: